The utility of MRI for the screening and staging of breast cancer

International Journal of Clinical Practice
N Patani, K Mokbel

Abstract

Contrast-enhanced magnetic resonance imaging (MRI) of the breast has been recently introduced as a potential clinical tool for the detection, diagnosis, staging and management of breast cancer. In this article, we consider the established and evolving roles of MRI with particular reference to screening in high risk women and staging of the primary tumour. Controversies are discussed in the context of the tumour biology and natural history of breast cancer. Articles were identified by searches of PubMed and MEDLINE up to October 2007. Contrast-enhanced MRI is an effective tool for screening women at high risk of breast cancer. However, randomized trials have yet to demonstrate a reduction in mortality. MRI can also facilitate local staging, in particular, the evaluation of ipsilateral multicentric or multifocal lesions and synchronous contralateral disease which may be 'missed' by conventional imaging. However, efficacy with respect to clinically relevant and patient oriented end-points has yet to be addressed in the context of clinical trials. In women at high risk of breast cancer, screening MRI should be used in conjunction with published guidelines. In women with newly diagnosed breast cancer, the utility of MRI is less clea...Continue Reading

References

Sep 1, 1996·British Journal of Cancer·J S VaidyaI Mittra
Jan 18, 1997·Lancet·M BaumI Mittra
Jan 18, 1997·Lancet·P J DrewJ N Fox
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L EssermanE Sickles
Aug 20, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Yu ZhangTakeo Ishigaki
Jan 24, 2003·AJR. American Journal of Roentgenology·Laura LibermanD David Dershaw
Feb 5, 2004·Journal of the American College of Surgeons·Monica Morrow
May 12, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K SchelfoutA De Schepper
Jul 30, 2004·The New England Journal of Medicine·Mieke KriegeUNKNOWN Magnetic Resonance Imaging Screening Study Group
Dec 9, 2004·JAMA : the Journal of the American Medical Association·David A BluemkeMitchell D Schnall
Dec 9, 2004·JAMA : the Journal of the American Medical Association·Monica Morrow
Jan 31, 2006·Archives of Physical Medicine and Rehabilitation·Ann E PoulosAngela H Dew
Aug 19, 2006·Magnetic Resonance Imaging·Ruth WarrenUNKNOWN UK MRC study of MRI screening for breast cancer in women at high risk (MARIBS)
Oct 4, 2006·British Journal of Cancer·I GriebschUNKNOWN UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group
Oct 13, 2006·Journal of Magnetic Resonance Imaging : JMRI·Constance D Lehman
Mar 30, 2007·The New England Journal of Medicine·Constance D LehmanUNKNOWN ACRIN Trial 6667 Investigators Group
Mar 30, 2007·The New England Journal of Medicine·Robert A Smith
Apr 17, 2007·American Journal of Surgery·J David Beatty, Bruce A Porter
Jun 8, 2007·The New England Journal of Medicine·Rinaa S PungliaJay R Harris
Jul 13, 2007·The New England Journal of Medicine·Mark Robson, Kenneth Offit
Aug 8, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S J LordN Houssami
Sep 7, 2007·The New England Journal of Medicine·Bernard Fisher, Stewart J Anderson
Oct 19, 2007·The New England Journal of Medicine·Francesco Sardanelli, Franca Podo

❮ Previous
Next ❯

Citations

Jun 21, 2011·European Radiology·Pierluigi RinaldiL Bonomo
Sep 19, 2012·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Anusheel MunshiUNKNOWN other Locoregional Panel Members
Oct 1, 2010·Journal of Magnetic Resonance Imaging : JMRI·Richard A E EddenPeter B Barker
Sep 26, 2015·Clinical Breast Cancer·Sneha PhadkeMary C Schroeder
Jul 29, 2010·Cancer Control : Journal of the Moffitt Cancer Center·Narges K TafreshiRobert A Gatenby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Breast : Official Journal of the European Society of Mastology
Vani ParmarRajendra Badwe
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
A MunshiK A Dinshaw
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Philip PoortmansEORTC Radiotherapy and Breast Cancer Groups
© 2021 Meta ULC. All rights reserved